Bioanalytical method transfer is a critical and often vulnerable step in drug development, yet many challenges arise not from technical limitations but from misalignment, communication gaps and loss of scientific context as work moves between organizations. The European Bioanalysis Forum conducted a multi-table Pharma/CRO workshop and community survey to identify the behaviors that most influence transfer success. The discussions revealed consistent themes: early SME engagement, shared understanding of scientific intent, proactive communication, joint risk management and a clear responsibility split. This paper summarizes these insights and provides practical, interaction-focused recommendations to strengthen collaboration across method development, transfer and validation. Rather than prescribing templates or checklists, the European Bioanalysis Forum outlines behaviors and principles that promote clarity, predictability and scientific convergence. Reliable method transfer emerges from partnership mind-set and deliberate interaction, not procedural formality.
Andersen et al. (Sun,) studied this question.